Literature DB >> 12117779

Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.

Tsutomu Shimada1, Kiyoshi Inoue, Yoshihiko Suzuki, Takao Kawai, Emiko Azuma, Takae Nakajima, Masaki Shindo, Kosuke Kurose, Atsushi Sugie, Yutaka Yamagishi, Yoshiaki Fujii-Kuriyama, Masafumi Hashimoto.   

Abstract

Arylhydrocarbon receptor knock-out, AhR(-/-), mice have recently been shown to be rather resistant to benzo[a]pyrene (B[a]P)-induced tumor formation, probably reflecting the inability of these mice to express significant levels of cytochrome P450 (P450 or CYP) 1A1 that activates B[a]P to reactive metabolites (Y. Shimizu, Y. Nakatsuru, M. Ichinose, Y. Takahashi, H. Kume, J. Mimura, Y. Fujii-Kuriyama and T. Ishikawa (2000) PROC: Natl Acad. Sci. USA, 97, 779-782). However, it is not precisely determined whether CYP1B1, another enzyme that is also active in activating B[a]P, plays a role in the B[a]P carcinogenesis in mice. To understand the basis of roles of CYP1A1 and CYP1B1 in the activation of chemical carcinogens, we compared levels of induction of liver and lung CYP1A1, 1A2, and 1B1 by various polycyclic aromatic hydrocarbons (PAHs) and polychlorinated biphenyls in AhR(+/+) and AhR(-/-) mice. Liver and lung CYP1A1 and 1B1 mRNAs were highly induced in AhR(+/+) mice by a single intraperitoneal injection of each of the carcinogenic PAHs, such as B[a]P, 7,12-dimethylbenz[a]anthracene, dibenz[a,l]pyrene, 3-methylcholanthrene, 1,2,5,6-dibenzanthracene, benzo[b]fluoranthene, and benzo[a]anthracene and by a co-planar PCB congener 3,4,3',4'-tetrachlorobiphenyl. We also found that 6-aminochrysene, chrysene, benzo[e]pyrene, and 1-nitropyrene weakly induced the mRNA expression of CYP1A1 and 1B1, whereas anthracene, pyrene, and fluoranthene that have been reported to be non-carcinogenic in rodents, were very low or inactive in inducing these P450s. The extents of induction of liver CYP1A2 by these chemicals were less than those of CYP1A1 and 1B1 in AhR(+/-/+/-) mice. In AhR(-/-) mice, there was no induction of these P450s by PAHs and polychlorinated biphenyls. Liver microsomal activities of 7-ethoxyresorufin and 7-ethoxycoumarin O-deethylations and of mutagenic activation of (+/-)-trans-7,8-dihydroxy-7,8-dihydro-B[a]P to DNA-damaging products were found to correlate with levels of CYP1A1 and 1B1 mRNAs in the liver. Our results suggest that carcinogenicity potencies of PAHs may relate to the potencies of these compounds to induce CYP1A1 and 1B1 through AhR-dependent manner and that these induced P450s participate in the activation of B[a]P and related carcinogens causing initiation of cancers in mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117779     DOI: 10.1093/carcin/23.7.1199

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  46 in total

1.  Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.

Authors:  Qingbiao Huang; Rahul S Deshmukh; Spencer S Ericksen; Youbin Tu; Grazyna D Szklarz
Journal:  Drug Metab Dispos       Date:  2012-09-04       Impact factor: 3.922

2.  Disruption of cytochrome P4501A2 in mice leads to increased susceptibility to hyperoxic lung injury.

Authors:  Lihua Wang; Krithika Lingappan; Weiwu Jiang; Xanthi I Couroucli; Stephen E Welty; Binoy Shivanna; Roberto Barrios; Gangduo Wang; M Firoze Khan; Frank J Gonzalez; L Jackson Roberts; Bhagavatula Moorthy
Journal:  Free Radic Biol Med       Date:  2015-02-10       Impact factor: 7.376

Review 3.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

4.  Dissociation of the AhR/ARNT complex by TGF-β/Smad signaling represses CYP1A1 gene expression and inhibits benze[a]pyrene-mediated cytotoxicity.

Authors:  Naoko Nakano; Nobuo Sakata; Yuki Katsu; Daiki Nochise; Erika Sato; Yuta Takahashi; Saori Yamaguchi; Yoko Haga; Souichi Ikeno; Mitsuyoshi Motizuki; Keigo Sano; Kohei Yamasaki; Keiji Miyazawa; Susumu Itoh
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

5.  Aryl hydrocarbon receptor-dependence of dioxin's effects on constitutive mouse hepatic cytochromes P450 and growth hormone signaling components.

Authors:  Chunja Lee; David S Riddick
Journal:  Can J Physiol Pharmacol       Date:  2012-09-14       Impact factor: 2.273

Review 6.  Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.

Authors:  Bhagavatula Moorthy; Chun Chu; Danielle J Carlin
Journal:  Toxicol Sci       Date:  2015-05       Impact factor: 4.849

7.  Multiphoton spectral analysis of benzo[a]pyrene uptake and metabolism in breast epithelial cell lines.

Authors:  Rola Barhoumi; Jeffrey M Catania; Alan R Parrish; Igbal Awooda; Evelyn Tiffany-Castiglioni; Stephen Safe; Robert C Burghardt
Journal:  J Toxicol Sci       Date:  2009-02       Impact factor: 2.196

8.  Benzo[a]pyrene induces intercellular adhesion molecule-1 through a caveolae and aryl hydrocarbon receptor mediated pathway.

Authors:  Elizabeth Oesterling; Michal Toborek; Bernhard Hennig
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-11       Impact factor: 4.219

9.  Atranorin and lecanoric acid antagonize TCDD-induced xenobiotic response element-driven activity, but not xenobiotic response element-independent activity.

Authors:  Ken-Ichi Nakashima; Hiroki Tanabe; Yoshiaki Fujii-Kuriyama; Hidetoshi Hayashi; Makoto Inoue
Journal:  J Nat Med       Date:  2016-03-15       Impact factor: 2.343

Review 10.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.